MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

“…(n = 3 - 10 mice per group; Data are presented as the mean ± standard error; *, **, ***, and **** indicate significance at p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively.).…”

Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0. by Danielle Sambo (6077924)

Effects of GJE extract treatment decreased accumulation of Col1a1. by Natnicha Suttawong (22367172)

ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”

Comparison of mean days of wound healing across different wound types for wounds healed in more than 3 months durations (2022 and 2023). by Heba Tallah Mohammed (2822432)

Comparison of mean days of wound healing across different wound types for wounds healed in less than 3 months durations (2022 and 2023). by Heba Tallah Mohammed (2822432)

No significant diurnal rhythmicity of short chain fatty acids in the blood was observed. by Weiran Shan (16969688)

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

Mean (SD) of fixation duration, fixation counts, and SAGAT accuracy according to scene complexity and autonomous driving information display type. by Chengmin Zhou (14554562)

Cat Stress Score (CSS) was significantly predicted by intake type and days in the study. by Allison Andrukonis (11846404)

Means scores of CAM and CAM-MYCS. by Senay Yildirim-Kahriman (22693464)

Meaning of Each Model. by Yutong Liu (4027994)

Mean body weight of different groups at baseline and along four weeks of experimental procedures. by Deborah Ribeiro Frazão (9188152)

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects: